Cochran Q test revealed evidence of heterogeneity among IVs estimates based on individual variation for IBD, MS, PsO, RA, and MG (P < .05), no heterogeneity was observed among IV estimates for the other 5 types of AID (Table 3). This evidence concerns the gene AICDA and myeloid sarcoma.